A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Clinical trial NCT01420081 · TERMINATED

Trial details

NCT number: NCT01420081
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Neoplasms

Start date: 2012-01-19
Primary completion: 2014-04-30
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.